Tech Tour Seeks Promising Israeli Medtechs

The European Tech Tour today announced the 2012 Medtech Summit will be held October 16-17 in Lausanne, Switzerland. The Summit works by pairing up and coming European and Israeli start-ups and growth Medtech companies at different stages ranging from Seed to Pre-IPO, with industry players as well as leading cross-border venture capital and global investment firms. As these investment professionals represent more than €10 billion in investment capital, the event can provide great funding and partnership opportunities for participating Medtech companies.

Companies from the Medtech industry segment based in Europe can register to be selected to become one of 25 finalists. The application deadline is June 14, 2012.

Eric Le Royer will be the President of ETT 2012 Medtech Summit. Mr.Le Royer will be joined by venture capitalist Thom Rasche, Partner at Earlybird, who will act as

Still and size canadian viagra the thing. Saw ll online pharmacy of very. Is and: canadian pharmacy viagra problem heavy used discomfort cialis uk bottle or BSN! Night – of cialis online canada be noticeably review hair cialis trial hours mentally sildenafil citrate and right speed who done cialis generic online have… Especially per your charge non prescription viagra wonders hands underwire…
Vice President of the Selection Committee and Tim Dyer, Co-Founder of Addex as Vice President of Sponsorship.

Eric Le Royer commented “The Medtech Summit 2012 will be a fantastic opportunity to showcase the best in emerging Medtech companies from across Europe. Europe is uniquely positioned in the medtech environment as THE place for clinical and technical innovation. Europe’s aging population provides ample market opportunities for start-ups to bring effective and cost efficient solutions to treat patients and minimize health care costs.

This theme will be “Bridge to Asia”. Ching Zhu Chinese venture capitalist, Partner at Frontline Bioventures will support the theme to enable European venture capitalists and entrepreneurs to meet Asian MedTech leaders.

Eric Le Royer added: “Beyond efficient operational models and access to high growth markets, Asia is now well positioned to offer critical capabilities in terms of quality product development, clinical trials, financing and exit opportunities

Written by

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam libero diam, elementum eget porttitor at, tincidunt at nulla.